Primary lung cancer shifts to metastatic disease by suppressing a family of small molecules that normally locks the tumor in a noninvasive state, researchers at The University of Texas M. D. Anderson Cancer Center report in the Genes and Development.
"Existing treatments have little success against cancer that has spread to other organs, so finding a way to prevent metastasis could have a huge impact on survival," said senior author Jonathan Kurie, M.D., professor in M. D. Anderson's Department of Thoracic/Head and Neck Medical Oncology.